Form 4 for TELA TELA Bio, Inc.
Accepted 2025-05-30 00:00:00 ET · period of report 2025-05-28 · accession 0001062993-25-010578 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-05-30 | 2025-05-28 | TELA | O'Brien Federica F. | Dir | A - Grant | $0.00 | +7,950 | 18.5K | +76% | $0 |
| D | 2025-05-30 | 2025-05-28 | TELA | O'Brien Federica F. | Dir | A - Grant | $0.00 | +11.7K | 11.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-28 | A | A | 7,950 | $0.00 | 18,470 | D | — | — | (F1) These restricted stock units vest on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-05-28 | A | A | 11,700 | $0.00 | 11,700 | D | $1.39 · — to 2035-05-28 | 11,700 Common Stock | (F2) The option vests on the earlier of (a) May 28, 2026, (b) the next annual meeting of stockholders, or (c) the occurrence of a Change in Control (as defined in the Issuer's Amended and Restated 2019 Equity Incentive Plan), in each case subject to the Reporting Person's continued service through the applicable vesting date. |